COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Grants and Funding


The Office of Grant Development assists UC San Diego Moores Cancer Center faculty members in pursuit of external research and training support, particularly large-scale program and center grants, and young investigator awards. Assistance is provided without cost under normal circumstances.
Services Offered

Upcoming Deadlines

November 2, 2020, 5pm
2020 Padres Pedal the Cause
Apply Now

 

2020 Padres Pedal the Cause

Now accepting applications
Deadline: Monday, November 2, 2020 @ 5:00pm (PST)

Proceeds from Padres Pedal the Cause are available to faculty members of the UC San Diego Moores Cancer Center to stimulate scientific collaboration and innovative translational cancer research in the basic, clinical, and population (public health) sciences. This RFA seeks applications in clinical or team science research across a wide spectrum of disease-focused areas to encourage greater breadth and depth related to the prevention, diagnosis, or treatment of cancer involving patients and populations. The research supported through this mechanism must have clinical/translational potential or significance.

Apply NowDownload the FAQ

Intramural Funding Opportunities

​A list of all current intramural funding opportunities at MCC. Updated monthly; if you are a member of the MCC community and have a funding opportunity to share, please contact CRCERA at crcera@health.ucsd.edu

​Internal Funding Opportunity
Application Deadline
Academic Senate Grants and Awards
October 15, 2020​
Cancer and COVID (donor funded thru MCC)Rolling basis​
D&I and DISC Pilot Project Grants, ACTRIDecember 1, 2020, 12pm PST
Faculty Funding and Award Opportunities
Various: check website
Foundation Relations Funding Opportunities
Various: check website​
Head and Neck SPORE
Contact for details
Pilot Grant Shark Tank CompetitionContact for details
Program in Immunology (in conjunction with Biological Sciences and LJI)Visit site for details
SDSU/UCSD Cancer Center Comprehensive Partnership
Visit site for details
UCSD Internal Funding and Limited SubmissionVarious: check website

Extramural Funding Opportunities

​As a service to our members, we provide a select list of current extramural funding opportunities that are unlimited or not administered directly by the MCC. Updated monthly. Additional NIH announcements may be found at this link:
View all NIH/NCI funding opportunities

​External Funding Opportunity
Application Deadline
American Cancer SocietyVisit site for details
LLS Specialized Center of Research ProgramVisit site for details
NCCN Limited Submission
Visit site for details​
V Foundation Limited SubmissionVisit site for details​


​NIH RFA Announcements
Application Deadline
CA20-044 Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)October 30, 2020
CA20-041 NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)November 9, 2020
CA20-034 NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)November 9, 2020
CA20-042 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)November 9, 2020
CA20-053 Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed)November 12, 2020
CA20-004 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)November 17, 2020
CA20-048 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)November 18, 2020
CA20-052 Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)November 18, 2020
CA20-013 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)November 18, 2020
CA20-012 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)November 18, 2020
CA20-011 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)November 18, 2020
CA20-010 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)November 18, 2020
CA20-009 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)November 18, 2020
CA20-008 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)November 18, 2020
CA20-007 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)November 18, 2020
CA20-005 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)November 18, 2020
CA20-047 Glioblastoma Therapeutics Network (U19 Clinical Trial Required)November 19, 2020
HD21-002 Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed)November 30, 2020
CA20-045 Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed)December 16, 2020
CA20-043 Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)January 20, 2021
CA20-040 Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)February 17, 2021
CA20-029 Metastasis Research Network (U54 Clinical Trial Not Allowed)May 28, 2021
CA20-031 Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)June 24, 2021
CA20-028 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)July 30, 2021
CA20-027 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)July 30, 2021
CA20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)December 14, 2021
CA20-051 Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)January 18, 2022

Grants and Funding Services


Service Guidelines

The OGD manager is available for advice about grant opportunities, help in developing and writing multidisciplinary proposals, and in proofing and editing final drafts of applications. If you are an approved faculty member of Moores Cancer Center and wish to receive assistance in these areas, please review the guidelines below.
The functions of the OGD are to:

  • Search for and disseminate key grant opportunities linked to the strengths and strategic objectives of Moores Cancer Center
  • Provide infrastructure support to the development of large scale, interdisciplinary program and center type proposals
  • Advise and counsel investigators on the rules and regulations of UC San Diego and major granting agencies on the application process
  • Assist young clinical investigators in pursuing and preparing peer-reviewed research grant applications
  • Prepare Moores Cancer Center core grant related applications
  • Maintain a database of UC San Diego and Moores Cancer Center resources suitable for inclusion in grant applications

How to Request Services

  • Contact Angela Ballantyne, PhD, stating the desired assistance. Straightforward tasks such as information will be promptly addressed.
  • Requests for assistance in grant preparation/coordination require the approval of the UC San Diego Moores Cancer Center director or his delegate.
  • Make requests for more involved assistance at least 60 days before the agency submission deadline.
  • Make requests for specific assignments and tasks. Service may be more limited than the request due to other assignments.
  • PIs must be willing to collaborate and cooperate on an application given competing demands on and limited scientific expertise of the OGD.
  • Under no circumstances will the OGD prepare the entire grant application for a PI.

Contact

Angela Ballantyne, PhD
Phone: 858-822-0182
E-mail: aballantyne@ucsd.edu